R
Robert Hatala
Researcher at Slovak Medical University
Publications - 47
Citations - 10181
Robert Hatala is an academic researcher from Slovak Medical University. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 12, co-authored 34 publications receiving 8144 citations. Previous affiliations of Robert Hatala include Goethe University Frankfurt.
Papers
More filters
Journal ArticleDOI
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti,William Wijns,Antti Saraste,Davide Capodanno,Emanuele Barbato,Christian Funck-Brentano,Eva Prescott,Robert F. Storey,Christi Deaton,Thomas Cuisset,Stefan Agewall,Kenneth Dickstein,Thor Edvardsen,Javier Escaned,Bernard J. Gersh,Pavel Svitil,Martine Gilard,David Hasdai,Robert Hatala,Felix Mahfoud,Josep Masip,Claudio Muneretto,Marco Valgimigli,Stephan Achenbach,Jeroen J. Bax +24 more
TL;DR: In this article, the authors present guidelines for the management of patients with coronary artery disease (CAD), which is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries.
Journal ArticleDOI
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm,Gregory Lip,Raffaele De Caterina,Irene Savelieva,Dan Atar,Stefan H. Hohnloser,Gerhard Hindricks,Paulus Kirchhof,Jeroen J. Bax,Helmut Baumgartner,Claudio Ceconi,Veronica Dean,Christi Deaton,Robert Fagard,Christian Funck-Brentano,David Hasdai,Arno W. Hoes,Juhani Knuuti,Philippe Kolh,Theresa McDonagh,Cyril Moulin,Bogdan A. Popescu,Željko Reiner,Udo Sechtem,Per Anton Sirnes,Michal Tendera,Adam Torbicki,Alec Vahanian,Stephan Windecker,Panos Vardas,Nawwar Al-Attar,Ottavio Alfieri,Annalisa Angelini,Carina Blomström-Lundqvist,Paolo Colonna,Johan De Sutter,Sabine Ernst,Andreas Goette,Bulent Gorenek,Robert Hatala,Hein Heidbuchel,Magnus Heldal,Steen Dalby Kristensen,Jean-Yves Le Heuzey,Hercules Mavrakis,Lluís Mont,Pasquale Perrone Filardi,Piotr Ponikowski,Bernard Prendergast,Frans H. Rutten,Ulrich Schotten,Isabelle C. Van Gelder,Freek W.A. Verheugt +52 more
TL;DR: A prospective, randomized, double blind, Active-controlled, superiority study of Vernakalant vs. amiodarone in Recent Onset atrial fibrillation for the prevention of cardiovascular Hospitalization or death from any cause.
Journal ArticleDOI
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Silvia G. Priori,Carina Blomström-Lundqvist,Andrea Mazzanti,Nico A. Blom,Martin Borggrefe,John Camm,Perry M. Elliott,Donna Fitzsimons,Robert Hatala,Gerhard Hindricks,Paulus Kirchhof,Keld Kjeldsen,Karl-Heinz Kuck,Antonio Hernández-Madrid,Nikolaos Nikolaou,Tone M. Norekvål,Christian Spaulding,Dirk J. van Veldhuisen +17 more
TL;DR: In this article, the authors proposed AMIOdarone versus implantable cardioverter-defibrillator (ICD-DV) for the treatment of atrial fibrillation.
Journal ArticleDOI
Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction
Stefan H. Hohnloser,Karl-Heinz Kuck,Paul Dorian,Robin S. Roberts,John R. Hampton,Robert Hatala,Eric Fain,Michael Gent,Stuart J. Connolly +8 more
TL;DR: Prophylactic ICD therapy does not reduce overall mortality in high-risk patients who have recently had a myocardial infarction, and is associated with a reduction in the rate of death due to arrhythmia, that was offset by an increase in the rates of death from nonarrhythmic causes.
Journal ArticleDOI
Suppression of paroxysmal atrial tachyarrhythmias — results of the SOPAT trial
Monica Patten,Renke Maas,Peter Bauer,Berndt Lüderitz,Frank Sonntag,Mirosław Dłużniewski,Robert Hatala,Grzegorz Opolski,Hans-Walter Müller,Thomas Meinertz +9 more
TL;DR: The Suppression of Paroxysmal Atrial Tachyarrhythmias (SOPAT) trial was designed to answer the following questions: (1) What is the average rate of spontaneous events of symptomatic PAF with and without anti-arrhythmic medication? (2) what is the prevalence of severe side effects? and (3) is the fixed combination of Quinidine+Verapamil inferior to the efficacy of sotalol or not?.